Komori
Soiken Holdings (2385) · PolicyFirst stated

Growth Investment and Shareholder Returns With Capital Costs and the Share Price in Mind

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Optimally Allocating Resources Among Growth Investment, Strengthening the Financial Base and Shareholder ReturnsA theme 346 companies write about · 2 as a headwind · 356 as a tailwind

4 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.Comparing 200 of the theme's 361 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「With regard to capital allocation, the Company will prioritize strategic growth investments, including research and development and systems investment to build a comprehensive healthcare platform, as well as M&A and other investments in the healthcare business, while ensuring financial soundness and enhancing shareholder returns.」

    For the first time, the Company separately presented a capital allocation policy that balances financial soundness and shareholder returns while prioritizing research and development, systems investment and M&A, as part of management focused on the cost of capital and share price.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Soiken Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Growth Investment and Shareholder Returns With Capital Costs and the Share Price in Mind | Soiken Holdings Inc. (2385) | Komori